| 造血干细胞移植治疗再生障碍性贫血(附视频) |
| |
| 引用本文： | 王军,陈虎.造血干细胞移植治疗再生障碍性贫血(附视频)[J].中华移植杂志（电子版）,2010,4(1):42-44. |
| |
| 作者姓名： | 王军 陈虎 |
| |
| 作者单位： | 解放军第307医院,北京,100071 |
| |
| 摘 要： | 再生障碍性贫血(简称再障)是一种获得性骨髓造血功能衰竭症。免疫抑制治疗或异基因造血干细胞移植是治愈重型再障的必要手段,对于年龄≤40岁的重型再障患者应首选HLA相合的同胞供者骨髓移植。30年来,随着移植技术的发展,重型再障患者的预后获得明显改善。本文就造血干细胞移植治疗再障的适应证及相关进展做一简要评述。
|
| 关 键 词： | 再生障碍性贫血 造血干细胞移植 免疫抑制 治疗 |
Hematopoietic stem cell transplantation for acquired aplastic anemia(video attached) |
| |
| WANG Jun,CHEN Hu.Hematopoietic stem cell transplantation for acquired aplastic anemia(video attached)[J].Chinese Journal of Transplanation(Electronic Version),2010,4(1):42-44. |
| |
| Authors: | WANG Jun CHEN Hu |
| |
| Affiliation: | WANG Jun,CHEN Hu. 307 Hospital of PLA,Beijing 100071,China |
| |
| Abstract: | Acquired aplastic anemia is a bone marrow failure syndrome. Immunosuppressive therapy and hematopoietic stem cell transplantation ( HSCT) are the only two available curative treatments to patients with severe aplastic anemia. It is generally recommended to consider bone marrow transplantation as first-line therapy for patients younger than 40 years old with severe aplastic anemia who have an HLA-identical sibling donor. Over the past 30 years,advances in HSCT have significantly improved the prognosis for se... |
| |
| Keywords: | Aplastic anemia Hematopoietic stem cell transplantation Immunosuppressive Therapy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
